Cotractile protein abnormalities in failing hearts

Journal of Nuclear Cardiology

Volumn 9, Issue 4, 2002, Pages 413-418

  Margulies, Kenneth B ^a  

^a TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIN; CALCIUM; CONTRACTILE PROTEIN; CYCLIC AMP DEPENDENT PROTEIN KINASE; MYOSIN; MYOSIN ADENOSINE TRIPHOSPHATASE; PROTEIN KINASE C;

ACTIN MYOSIN INTERACTION; ARTICLE; CONTROLLED STUDY; ENZYME PHOSPHORYLATION; GENE MUTATION; HEART FAILURE; HUMAN; MOLECULAR DYNAMICS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN PROCESSING; SARCOMERE; CONGENITAL HEART MALFORMATION; CONGESTIVE HEART FAILURE; GENETICS; PHYSIOLOGY; REVIEW;

CONTRACTILE PROTEINS; HEART DEFECTS, CONGENITAL; HEART FAILURE, CONGESTIVE; HUMANS;

EID: 0036628604     PISSN: 10713581     EISSN: None     Source Type: Journal    
DOI: 10.1067/mnc.2002.125812     Document Type: Review

References (48)

1. Solaro RJ, Rarick HM. Troponin and tropomyosin: proteins that switch on and tune in the activity of cardiac myofilaments. Circ Res 1998;83:471-80.
2. Tobacman LS. Thin filament-mediated regulation of cardiac contraction. Ann Rev Physiol 1996;58:447-81.
3. Kavaler F, Morad M. Paradoxical effects of epinephrine on excitation-contraction coupling in cardiac muscle. Circ Res 1966;18:492-7.
4. Towbin JA. Molecular genetics of hypertrophic cardiomyopathy. Curr Cardiol Rep 2000;2:134-40.
5. Nimura H, Patton KK, McKenna WJ, Soults J, Maron BJ, Seidman JG, et al. Sarcomere protein gene mutations in hypertrophic cardiomyopathy of the elderly. Circulation 2002; 105:446-51.
6. Olson TM, Michels VV, Thibodeau SN, Tai YS, Keating MT. Actin mutations in dilated cardiomyopathy, a heritable form of heart failure. Science 1998;280:750-2.
7. Olson TM, Kishimoto NY, Whitby FG, Michels VV. Mutations that alter the surface charge of alpha-tropomyosin are associated with dilated cardiomyopathy. J Mol Cell Cardiol 2001;33: 723-32.
8. Fujino N, Shimizu M, Ino H, Yamaguchi M, Yasuda T, Nagata M, et al. A novel mutation Lys273Glu in the cardiac troponin T gene shows high degree of penetrance and transition from hypertrophic to dilated cardiomyopathy. Am J Cardiol 2002;89: 29-33.
9. Kamisago M, Sharma SD, DePalma SR, Solomon S, Sharma P, McDonough B, et al. Mutations in sarcomere protein genes as a cause of dilated cardiomyopathy. N Engl J Med 2000;343:1688-96.
10. Pagani ED, Alousi AA, Grant AM, Older TM, Dziuban SW Jr, Allen PD. Changes in myofibrillar content and Mg-ATPase activity in ventricular tissues from patients with heart failure caused by coronary artery disease, cardiomyopathy, or mitral valve insufficiency. Circ Res 1988;63:380-5.
11. Kubo H, Margulies KB, Piacentino V III, Gaughan JP, Houser SR. Patients with end-stage congestive heart failure treated with beta-adrenergic receptor antagonists have improved ventricular myocyte calcium regulatory protein abundance. Circulation 2001;104:1012-8.
12. Ojamaa K, Samarel AM, Kupfer JM, Hong C, Klein I. Thyroid hormone effects on cardiac gene expression independent of cardiac growth and protein synthesis. Am J Physiol 1992;263: E534-40.
13. Nakao K, Minobe W, Roden R, Bristow MR, Leinwand LA. Myosin heavy chain gene expression in human heart failure. J Clin Invest 1997;100:2362-70.
14. Black FM, Packer SE, Parker TG, Michael LH, Roberts R, Schwartz RJ, et al. The vascular smooth muscle alpha-actin gene is reactivated during cardiac hypertrophy provoked by load. J Clin Invest 1991;88:1581-8.
15. Adachi S, Ito H, Tamamori M, Tanaka M, Marumo F, Hiroe M. Skeletal and smooth muscle alpha-actin mRNA in endomyocardial biopsy samples of dilated cardiomyopathy patients. Life Sci 1998;63:1779-91.
16. Morano M, Zacharzowski U, Maier M, Lange PE, Alexi-Meskishvili V, Haase H, et al. Regulation of human heart contractility by essential light chain isoforms. J Clin Invest 1996;98:467-73.
17. Fitzsimons DP, Patel JR, Moss RL. Role of myosin heavy chain composition in kinetics of force development and relaxation in rat myocardium. J Physiol 1998;513:171-83.
18. Herron TJ, Korte FS, McDonald KS. Loaded shortening and power output in cardiac myocytes are dependent on myosin heavy chain isoform expression. Am J Physiol Heart Circ Physiol 2001;281:H1217-22.
19. 2+-activated tension development in single adult cardiac myocytes. Circ Res 1999;84:1310-7.
20. Ritter O, Luther HP, Haase H, Baltas LG, Baumann G, Schulte HD, et al. Expression of atrial myosin light chains but not alpha-myosin heavy chains is correlated in vivo with increased ventricular function in patients with hypertrophic obstructive cardiomyopathy. J Mol Med 1999;77:677-85.
21. Wattanapermpool J, Guo X, Solaro RJ. The unique amino-terminal peptide of cardiac troponin I regulates myofibrillar activity only when it is phosphorylated. J Mol Cell Cardiol 1995;27:1383-91.
22. Kentish JC, McCloskey DT, Layland J, Palmer S, Leiden JM, Martin AF, et al. Phosphorylation of troponin I by protein kinase A accelerates relaxation and crossbridge cycle kinetics in mouse ventricular muscle. Circ Res 2001;88:1059-65.
23. Holroyde MJ, Howe E, Solaro RJ. Modification of calcium requirements for activation of cardiac myofibrillar ATPase by cAMP dependent phosphorylation. Biochem Biophys Acta 1979; 586:63-9.
24. 2+-regulatory site of bovine cardiac troponin. J Biol Chem 1982;257:260-3.
25. Herron TJ, Korte FS, McDonald KS. Power output is increased after phosphorylation of myofibrillar proteins in rat skinned cardiac myocytes. Circ Res 2001;89:1184-90.
26. Gruen M, Prinz H, Gautel M. cAPK-phosphorylation controls the interaction of the regulatory domain of cardiac myosin binding protein C with myosin-S2 in and on-off fashion. FEBS Lett 1999;453:254-9.
27. Fentze RC, Buck SH, Patel JR, Lin H, Wolska BM, Stojanovic MO, et al. Impaired cardiomyocyte relaxation and diastolic function in transgenic mice expressing slow skeletal troponin I in the heart. J Physiol 1999;517:143-57.
28. de Tombe PP, Ter Keurs HEDJ. Lack of the effect of isoproterenol on unloaded velocity of sarcomere shortening in rat cardiac trabeculae. Circ Res 1992;68:382-91.
29. Janssen PML, de Tombe PP. Protein kinase A does not alter unloaded velocity of sarcomere shortening in skinned rat cardiac trabeculae. Am J Physiol Heart Circ Physiol 1997;42:H2415-22.
30. Strang KT, Sweitzer NK, Greaser ML, Moss RL. β-Adrenergic receptor stimulation increases unloaded shortening velocity of skinned single ventricular myocytes from rats. Circ Res 1994;74: 542-9.
31. Li L, Desantiago J, Chu G, Kranias EG, Bers DM. Phosphorylation of phospholamban and troponin I in β-adrenergic-induced acceleration of cardiac relaxation. Am J Physiol Heart Circ Physiol 2000;278:H769-79.
32. Schwinger RH, Bohm M, Koch A, Schmidt U, Morano I, Eissner HJ, et al. The failing human heart is unable to use the Frank-Starling mechanism. Circ Res 1994;74:959-69.
33. Wolff MR, Buck SH, Stoker SW, Greaser ML, Mentzer RM. Myofibrillar calcium sensitivity of isometric tension is increased in human dilated cardiomyopathies: role of altered beta-adrenergically mediated protein phosphorylation. J Clin Invest 1996;98:167-76.
34. Wolff MR, Whitesell LF, Moss RL. Calcium sensitivity of isometric tension is increased in canine experimental heart failure. Circ Res 1995;76:781-9.
35. McConnell BK, Moravec CS, Bond M. Troponin I phosphorylation and myofilament calcium sensitivity during decompensated cardiac hypertrophy. Am J Physiol Heart Circ Physiol 1998;43:H385-96.
36. Bodor GS, Oakeley AE, Allen PD, Crimmins DL, Ladenson JH, Anderson PAW. Troponin I phosphorylation in the normal and failing adult human heart. Circulation 1997;96:1495-500.
37. Zakhary DR, Moravec CS, Stewart RW, Bond M. Protein kinase A (PKA)-dependent troponin I phosphorylation and PKA regulatory subunits are decreased in human dilated cardiomyopathy. Circulation 1999;99:505-10.
38. Hajjar RJ, Schwinger RH, Schmidt U, Kim CS, Lebeche D, Doye AA, et al. Myofilament calcium regulation in human myocardium. Circulation 2000;101:1679-85.
39. Fink MA, Zakhary DR, Mackey JA, Desnoyer RW, Apperson-Hansen C, Damron DS, et al. AKAP-mediated targeting of protein kinase A regulates contractility in cardiac myocytes. Circ Res 2001;88:291-7.
40. 2+-dependent protein kinase. Biochem J 1983;209:189-95.
41. 2+ sensitivity in intact and skinned muscles from normal and diseased human myocardium. Circ Res 1990;67:744-52.
42. Noland TA Jr, Raynor RL, Kuo JF. Identification of sites phosphorylated in bovine cardiac troponin I and troponin T by protein kinase C and comparative substrate activity of synthetic peptides containing the phosphorylation sites. J Biol Chem 1989; 264:20778-85.
43. (2+)-stimulated MgATPase of reconstituted actomyosin S-1. J Biol Chem 1995;270:25445-54.
44. Montgomery DE, Chandra M, Huang Q, Jin J, Solaro RJ. Transgenic incorporation of skeletal TnT into cardiac myofilaments blunts PKC-mediated depression of force. Am J Physiol Heart Circ Physiol 2001;280:H1011-8.
45. Hein S, Scheffold T, Schaper J. Ischemia induces early changes to cytoskeletal and contractile proteins in diseased human myocardium. J Thorac Cardiovasc Surg 1995; 110:89-98.
46. 2+ responsiveness and altered diastolic function in intact ventricular muscle. Circ Res 1995;76:1036-48.
47. McDonough JL, Arrello DK, Van Eyk JE. Troponin I degradation and covalent complex formation accompanies myocardial ischemia/reperfusion injury. Circ Res 1999;84:
48. Feng J, Schaus BJ, Fallavollita JA, Lee TC, Canty JM. Preload induces troponin I degradation independently of myocardial ischemia. Circulation 2001;103:2035-7.